DAN SAMUEL KAUFMAN, MD
Osteopathic Medicine in Minneapolis, MN
License number
Minnesota 45009
Category
Osteopathic Medicine
Type
Hematology
Address
Address
516 Suite 500 FLOOR FIFTH, Minneapolis, MN 55455
Phone
(612) 626-2663
Personal information
See more information about DAN SAMUEL KAUFMAN at radaris.comName
Address
Phone
8391 Hidden Ponds Alcove, Saint Paul, MN 55125
1200 Oakcrest Ave, Roseville, MN 55113
57743 285Th St, Deer Creek, MN 56527
218 Howard Ave, Wadena, MN 56482
6 Marilyn, Crane Lake, MN 55725
Professional information
Professor Of Medicine And Associate Director Of Stem Cell Institute At University Of Minnesota
Position:
Professor of Medicine and Associate Director of Stem Cell Institute at University of Minnesota
Location:
Greater Minneapolis-St. Paul Area
Industry:
Research
Work:
University of Minnesota
- Greater Minneapolis-St. Paul Area since Jul 2002
-
Professor of Medicine and Associate Director of Stem Cell Institute
University of Wisconsin-Madison
1996 - 2002
-
Medical Resident, Hematology Fellowship and Post-Doctoral Fellowship
Education:
Mayo Medical School 1989 - 1996
MD, PhD, Medicine and Immunology Stanford University 1984 - 1988
B.S., Biological Sciences
MD, PhD, Medicine and Immunology Stanford University 1984 - 1988
B.S., Biological Sciences
Skills:
Stem Cells, Regenerative Medicine, Cancer, Immunology, Cell Culture, Flow Cytometry, Life Sciences, Clinical, Hematology, Cell Therapy, Lifesciences, Cell, Biotechnology, Clinical Research, Genetics, Molecular Biology
Dr. Dan S Kaufman, Burnsville MN - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
201 E Nicollet Blvd, Burnsville 55337
(952) 892-2000 (Phone)
516 Delaware St SE, Minneapolis 55455
(612) 626-6100 (Phone)
5200 Fairview Blvd, Wyoming 55092
(651) 982-7000 (Phone)
Fairview Northland Medical Center
911 Northland Dr, Princeton 55371
(763) 389-1313 (Phone)
(952) 892-2000 (Phone)
516 Delaware St SE, Minneapolis 55455
(612) 626-6100 (Phone)
5200 Fairview Blvd, Wyoming 55092
(651) 982-7000 (Phone)
Fairview Northland Medical Center
911 Northland Dr, Princeton 55371
(763) 389-1313 (Phone)
Certifications:
Hematology, 2012, Internal Medicine, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
201 E Nicollet Blvd, Burnsville 55337
516 Delaware St SE, Minneapolis 55455
5200 Fairview Blvd, Wyoming 55092
Fairview Northland Medical Center
911 Northland Dr, Princeton 55371
University of Minnesota Medical Center Fairview - West Bank
2312 6Th St South, Minneapolis 55454
516 Delaware St SE, Minneapolis 55455
5200 Fairview Blvd, Wyoming 55092
Fairview Northland Medical Center
911 Northland Dr, Princeton 55371
University of Minnesota Medical Center Fairview - West Bank
2312 6Th St South, Minneapolis 55454
Education:
Medical School
Mayo Medical School
Graduated: 1996
University Wisc Hosps/Clins
Graduated: 1997
Graduated: 1999
Mayo Medical School
Graduated: 1996
University Wisc Hosps/Clins
Graduated: 1997
Graduated: 1999
Dan Samuel Kaufman, Minneapolis MN
Specialties:
Hematologist
Address:
516 Delaware St Se, Minneapolis, MN 55455
420 Delaware St Se, Minneapolis, MN 55455
420 Delaware St Se, Minneapolis, MN 55455
Education:
Mayo Clinic College of Medicine - Doctor of Medicine
University of Wisconsin Hospital & Clinics - Residency - Internal Medicine
University of Wisconsin Hospital & Clinics - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)
President At Kaufman Sign Company
Position:
PRESIDENT at KAUFMAN SIGN COMPANY
Location:
Greater Minneapolis-St. Paul Area
Industry:
Graphic Design
Work:
KAUFMAN SIGN COMPANY
-
PRESIDENT
Method For Developing Natural Killer Cells From Stem Cells
US Patent:
2013028, Oct 31, 2013
Filed:
Apr 23, 2013
Appl. No.:
13/868785
Inventors:
Dan S. KAUFMAN - Minneapolis MN, US
David A. KNORR - Minneapolis MN, US
David A. KNORR - Minneapolis MN, US
International Classification:
C12N 5/0783, A61K 35/14
US Classification:
424 9371, 435377, 435372, 435373
Abstract:
A method for producing NK cells from pluripotent stem cells, which includes culturing pluripotent stem cells in a first serum-free medium, aggregating the undifferentiated stem cells to form embryoid bodies, which are cultured to produce hematopoietic precursor cells, and culturing the precursor cells in a serum-free medium to produce the NK cells. Methods for using such NK cells, e.g., in the treatment of cancer and infectious disease are also provided.